Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching

Discussion on the paper by Spiegelhalter, Best, Carlin and van der Linde

ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) · 2002 · 12.8K citations

Engineering, Economics, Stochastic Processes +1

Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

Rafael G. Amado, Michael Wolf, Marc Peeters et al. · Journal of Clinical Oncology · 2008 · 3.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Statistical Models Based on Counting Processes

Xavier Bry, Per Kragh Andersen, Ørnulf Borgan et al. · Population · 1997 · 2.9K citations

Natural Sciences, Biostatistics, Mathematics +15

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer

Eric Van Cutsem, Marc Peeters, Salvatore Siena et al. · Journal of Clinical Oncology · 2007 · 2K citations

Medicine, Oncology, Pharmacology +14

Adaptive Rejection Sampling for Gibbs Sampling

Walter R. Gilks, Pascal Wild · Journal of the Royal Statistical Society Series C (Applied Statistics) · 1992 · 1.7K citations

Computing, Immunology, Bayesian Data Analysis +15